News 2024-05-16
Porton at CPhI North America again
We've had an exciting few days at CPhI North America. We want to express our sincere gratitude to all the present and potential future partners we've engaged with. Whether you require assistance with API route scouting, chemistry optimization, or the manufacturing of intermediates, RSM, or finished API, our teams are ready to support you from our locations in Cranbury (NJ), Slovenia, or our sites in China.
If you are focused on drug product development, the Porton team is equipped to aid in the development of tablets, capsules, liquids, or sterile products, starting from pre-formulation and DS-DP coprocessing through to GMP manufacturing, including high-potent product capabilities. Additionally, our global reach extends to the development of topical and transdermal patch products. How can Porton help you? Contact us.
|
Small Molecules CDMO |
TIDES CDMO |
Biologics (Antibody & ADCs) CDMO |
|
|
|
Others
More
News 2026-09-17
Porton Congratulates Partner Acepodia on FDA and NMPA IND Approvals for ACE723, a Dual-Payload ADC
This project demonstrates Porton's process-development and scale-up capabilities for complex conjugates and adds to its experience supporting innovative biopharma companies worldwide.
News 2026-09-15
Porton Chongqing Liangjiang Drug Product Manufacturing Site Earns Recertification of ISO 14001 & ISO 45001
This successful recertification highlights the standardized operation of the site's management systems, the rigor of its on-site management, and the robustness of its risk control mechanisms, further validating the continued effectiveness of the dual systems.
